Fuenzalida, Fernando (Endress+Hauser 2012–201705 Supervisory Board Member before CFO 1998–2012) |
Supervisory Board Member |
Endress+Hauser (Group) |
Switzerland |
Fuhge, Peter |
n. a. |
Affimed (Group) |
Germany |
Fuhr, Günter R. (Fraunhofer 201402 Head of Fraunhofer IBMT) |
Professor |
Fraunhofer (Group) |
Germany |
Fuhrer, David (Neopharm Group (IL) 201307 CEO + Owner) |
Chief Executive Officer (CEO) |
Neopharm (IL) (Group) |
Israel |
Fujita, Makoto (Univ Tokyo 201906 Prof at Univ Tokyo + Institute for Molecular Science) |
Professor |
University of Tokyo |
Japan |
Fulpius, Nicolas (Affentranger Associates 200803 Partner before Ultreia Capital Investment Director) |
Partner (venture partner) |
Affentranger Associates S.A. |
Switzerland |
Fulton, Gemma (BioOutsource 201406 Sales + Marketing Associate) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
United Kingdom (GB) |
Funk, Günter (Mikromol 200503 founder) |
Company Founder |
LGC (Group) |
Germany |
Funk, Lucas (Hamburg (govt) 202101 at Innovationsstarter Fonds Hamburg) |
Investment Manager |
Hamburg (govt region) |
Germany |
Funk, Marc (Lonza 201903–202001 CEO before COO of Pharma+Biotech division joined Lonza 1/09 LEFT 1/20) |
Chief Executive Officer (CEO) |
Lonza (Group) |
Switzerland |
Furch, Marcus (Rodos BioTarget 200905 CEO) |
Chief Executive Officer (CEO) |
Rodos BioTarget GmbH |
Germany |
Furmanski, Laura (Qiagen 2014–201711 Head of Bioinformatics Business Area RESIGNED END 2017) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
Germany |
Furst, David (Mediq Innovation Experts LLC 201707 Managing Partner befoer LifeSci + GILSC 201109) |
Managing Partner |
Mediq Innovation Experts (Group) |
Israel |
Furuishi, Kazuchika (Showa Denko 202009 Head Minaris Regenerative Medicine business + CEO Minaris LLC |
Chief Executive Officer (CEO) |
Showa Denko (SDK) (Group) |
United States (USA) |
Futch, Clarke B. (HealthCare Royalty Partners 201409 founding Managing Director) |
Managing Director |
HealthCare Royalty Partners (HC Royalty) |
United States (USA) |
Füglister, Michael (Cabinet Privé de Conseils 202009) |
Public Relations Manager / Investor Relations Manager |
Cabinet Privé de Conseils S.A. |
Switzerland |
Fünfschilling, Hans (früher Roche) |
Governmental Officer (personnel) |
Switzerland (govt) |
Switzerland |
Fürmeier, Sven (Univ Kassel 200908 Institute for Chemistry, Mass Spectrometry) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Kassel |
Germany |
Fürstenberg-Brock (Deutsche Messe 201009 Projektleiter Biotechnica) |
Event Manager / Conference Manager |
Deutsche Messe AG |
Germany |
Fürstner, Alois (Max Planck 1993– MPI for Coal Research Mühlheim) |
Professor |
Max Planck Society for the Advancement of Science |
|
Fäh, Urban (Bruker Corp 201802 President of Bruker Optics) |
President/Director/Head Business Group/Unit/Division |
Bruker BioSciences (Group) |
|
Färber, Nico (Thermo Fisher 201710 Patheon Business Development Executive Pharma Services) |
Business Development Manager / Strategy Manager |
Thermo Fisher (Group) |
Canada |
Fäs, Stefan (BioMedPartners 201702 CFO) |
Chief Financial Officer (CFO) |
BioMedPartners (Group) |
Switzerland |
Fässler, Christoph (Metrohm 201107 CEO) |
Chief Executive Officer (CEO) |
Metrohm (Group) |
Switzerland |
Föll, Armin (GC biotech 200809) |
n. a. |
GC biotech (Group) |
Germany |
Föller, Andreas (Comites 202102 Managing Director + Founder) |
Managing Director |
Comites GmbH (incl. brand Cardea Life Science) |
Germany |
Förster, Hans-Heinrich (Genolytic 201109 Managing Director) |
Managing Director |
Genolytic GmbH |
Germany |
Förtsch, Bernd (BF Holding) |
Managing Director |
BF Holding (Group) |
Germany |
Gaal, Lubor (Locust Walk 201807– SVP + Head of Europe before Almirall + BMS + Neuro3d + Vectron Therapeutics) |
Consultant (economic/technology) |
Locust Walk (Group) |
United Kingdom (GB) |
Gabel, Detlef (Univ Bremen 200911 Prof Organic Chemistry + Kooperationszentrum Medizin) |
Professor |
University of Bremen |
Germany |
Gabert, Jörg (Priontype 200602 Managing Director) |
Managing Director |
Qiagen (Group) |
Germany |
Gabor, E. Allan (Merck (DE) 201801 MAnaging Director + Country Speaker China joined 2013 before Pfizer China) |
Regional manager |
Merck (DE) (Group) |
Germany |
Gabriel, Raimund (MC Services 1999–201101– Founder + CEO) |
Chief Executive Officer (CEO) |
MC Services AG |
Germany |
Gabriel, Sigmar (Germany (govt) 2014 Minister of Economic Affairs and Energy) |
Minister |
Germany (govt) |
Germany |
Gabrielczyk, Thomas |
n. a. |
Biocom (Group) |
Germany |
Gadicke, Ansbert (MPM Capital 201604 Bioventure Investment Manager + Co-Founder) |
Investment Manager |
MPM Capital (Group) |
United States (USA) |
Gahlmann, Reinhold (Biofrontera 200601– Managing Director before 15y Bayer Pharma AG) |
Managing Director |
Biofrontera (Group) |
Germany |
Gaillard, Pierre (Servier 201702 Director of Global Marketing) |
Sales Manager / Marketing Manager |
Servier (Group) |
France |
Gaillard, Pieter J. (to-BBB 200902– CSO before CEO) |
Chief Executive Officer (CEO) |
2-BBB Medicines (Group) |
Netherlands |
Gaissmaier, Christoph (B Braun 201307 Executive Manager) |
Board member, executive |
B. Braun (Group) |
Germany |
Galakatos, Nicholas (Clarus Ventures 200906 Managing Director + co-founder) |
Managing Director |
Blackstone (Group) |
United States (USA) |
Galbraith, Daniel (BioOutsource 201402 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Sartorius (Group) |
United Kingdom (GB) |
Galbraith, Susan (AstraZeneca 201212 VP + Head Oncology Innovative Medicines Unit) |
President/Director/Head Business Group/Unit/Division |
AstraZeneca (Group) |
United Kingdom (GB) |
Galdos, Aitor (Tecan 2003–200412 CEO left because of differences over operational management with Board) |
Chief Executive Officer (CEO) |
Tecan (Group) |
Switzerland |
Gale, James (Signet Healthcare Partners 201507 Managing Director) |
Managing Director |
Signet Healthcare Partners (US) |
United States (USA) |
Gales, Ann (A Gales Consulting 201709 Managing Partner) |
Managing Partner |
A Gales Consulting Ltd. |
United Kingdom (GB) |
Galfetti, Paolo (APR Applied Pharma Research 201505 CEO) |
Chief Executive Officer (CEO) |
APR Applied Pharma Research S.A. |
Switzerland |
Gall, Karsten (Ionovation 201206 Managing Director) |
Managing Director |
Ionovation GmbH |
Germany |
Gallagher, Katie (LaVoieHealthScience 201909) |
Public Relations Manager / Investor Relations Manager |
LaVoieHealthScience (LHS) |
United States (USA) |
Gallagher, Stephen (Steve) (Dotmatics 200612 CEO) |
Chief Executive Officer (CEO) |
Insightful Science (Group) |
United Kingdom (GB) |
Galli, Roberto (Newron 201504 VP Finance) |
Chief Financial Officer (CFO) |
Newron (Group) |
Italy |
Galon, Jérôme (INSERM 201507 + Co-Founder of HalioDx) |
Researcher (university / research institute) |
France (govt) |
France |
Galonska, Erez (Infarm 202009 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Infarm – Indoor Urban Farming GmbH |
Germany |
Galuschka, Nicole (MC Services 201705) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
Galvin, Bob (Bruker Corp 201411 VP Biopharmaceutical Business Unit) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
United States (USA) |
Gamber, Michael (Merck (DE) 201507 Head of Merck Innovation Center) |
n. a. |
Merck (DE) (Group) |
Germany |
Gambillara Fonck, Veronica (LimmaTech Biologics 201508 Managing Director) |
Managing Director |
LimmaTech Biologics AG |
Switzerland |
Gamer, Jürgen (Apogenix 200810 VP BusDev) |
Business Development Manager / Strategy Manager |
Apogenix GmbH |
Germany |
Gammack, Jason T. (Resolve Biosciences 202011– CEO + Co-Founder before Inscripta + Qiagen + Ingenuity Systems) |
Chief Commercial Officer (CCO) |
Resolve Biosciences GmbH |
Germany |
Gammelin, Johann-Caspar (Evonik 202003 Chair Board of Management of Evonik Nutrition + Care) |
President/Director/Head Business Group/Unit/Division |
Evonik (Group) |
Germany |
Ganal, Martin (TraitGenetics GmbH 2000– Managing Director + Founder) |
Managing Director |
SGS (Group) |
Germany |
Ganten, Detlev |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Ganyushin, Albert (Euronext 201511 Head of International Listings) |
n. a. |
Euronext (Group) |
Netherlands |
Garaguso, Ignazio (Omnilab 201202 Product Specialist Chromatography Service) |
n. a. |
Omnilab (DE) (Group) |
Germany |
Garaud, Jean-Jacques (Inotrem 201403 CEO before Roche –201206 Global Head pRED) |
President/Director/Head Business Group/Unit/Division |
Inotrem S.A. |
France |
Gardner, Chris (Consilium 201507– Partner before since 2003 at Citigate Dewe Rogerson London) |
Public Relations Manager / Investor Relations Manager |
Consilium Strategic Communications Ltd. (CSC) |
United Kingdom (GB) |
Gardner, Jason (Magenta Therapeutics 201611 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Magenta Therapeutics Inc. |
United States (USA) |
Garguilo, Pia (Qiagen 201004– Senior Director Pharma Business Development before AstraZenca LP) |
Business Development Manager / Strategy Manager |
Qiagen (Group) |
Germany |
Garijo, Belén (Merck (DE) 202007– promoted Deputy CEO before CEO of Merck Serono before COO before Sanofi) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Germany |
Garnebode, Nils (Shimadzu 201404 Head Product Support + Marketing at Shimadzu Deutschland Gmb) |
Sales Manager / Marketing Manager |
Shimadzu Deutschland GmbH |
Germany |
Garnier, Jean-Pierre (Pierre Fabre Labs 2008–2010 CEO before GSK 2001–2008 CEO before SmithKline Beecham CEO) |
Chief Executive Officer (CEO) |
GlaxoSmithKline (GSK) (Group) |
United Kingdom (GB) |
Garotti, Alberto (JSR Corp 201801– CFO of Selexis SA before Coty Inc + Unilever) |
Chief Financial Officer (CFO) |
JSR Corporation (Group) |
Switzerland |
Garraway, Levi (Roche 201910– CMO + Head of Global Product Development before Lilly + Harvard + Foundation Medicine) |
Chief Medical Officer (CMO) |
Roche (Group) |
United States (USA) |
Garrett, Dave (Nabriva 201709 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Nabriva (Group) |
Austria |
Garthoff, Bernward (Nordrhein-Westfalen (govt) 2010 Head of BIO.NRW before Bayer CropScience 200506) |
Business Development Manager / Strategy Manager |
Nordrhein-Westfalen (govt region) |
Germany |
Gasper, Roger (MLM Medical Labs 202102– CFO before MaSTherCell + Clinical Supplies Management + JG Wentworth Company) |
Chief Financial Officer (CFO) |
MLM Medical Labs (Group) |
Germany |
Gasteiger, Johann (Univ Erlangen-Nuremberg 1994–) |
Company Founder |
University of Erlangen-Nuremberg (Friedrich Alexander University, FAU) |
Germany |
Gatenholm, Erik (Cellink 201908 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Cellink (Group) |
Sweden |
Gates, William Henry (Bill), III |
n. a. |
Bill and Melinda Gates Foundation |
United States (USA) |
Gatter, Jochen (AnalytiCon Discovery GmbH 2007) |
n. a. |
BRAIN (Group) |
Germany |
Gatzemeier, Susanne (Global Fairs 201504) |
n. a. |
Global Fairs (FR) |
France |
Gauer, Christoph (Olympus 200901 before Advalytix 200011– co-founder + CEO) |
Chief Executive Officer (CEO) |
Danaher (Group) |
Germany |
Gausepohl, Herr (Intavis 200809) |
Sales Manager / Marketing Manager |
HB Technologies (Group) |
Germany |
Gavlas, Jozef (Medirex Group 201801 CEO) |
Chief Executive Officer (CEO) |
Medirex Group (CZ/SK) |
Slovak Republic (Slovakia) |
Gaweco, Anderson (Apeiron 201808– CMSO before Innovimmune Biotherapeutics + Lifecycle Pharma + Roche + Pfizer) |
Chief Medical Officer (CMO) |
Apeiron (Group) |
Austria |
Gdynia, Georg (EnFin GmbH 201707– Managing Director) |
Managing Director |
EnFin GmbH |
Germany |
Gebauer, Alexander (Secarna 202102– Managing Director (CEO) before Omeicos + Sun Pharma + Ranbaxy + Merz Pharma) |
Chief Executive Officer (CEO) |
Secarna (Group) |
Germany |
Gebauer, Michael (Cardiac Research GmbH 201209 Managing Director + Cortag GmbH Managing Director) |
Managing Director |
Cardiac Research GmbH |
Germany |
Gedeon, Nora (QPS 201404 Director Business Development Clinical Research at QPS Austria GmbH) |
Business Development Manager / Strategy Manager |
QPS (Group) |
Austria |
Gedig, Erk (XanTec Bioanalytics 201108 Managing Director) |
Managing Director |
XanTec Bioanalytics GmbH |
Germany |
Geerds, Arno (Ribocon 2005– co-founder + managing director) |
Managing Director |
Ribocon GmbH |
Germany |
Gehlsen, Kurt R. (Research Corporation Technologies 201412 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
RCT (Group) |
United States (USA) |
Geissler, Holger (ipOcean Global GmbH 202004 Managing Director) |
Managing Director |
ipOcean Global GmbH |
Germany |
Gelber, Jeremy (Pamplona Capital 201706 Partner) |
Chief Executive Officer (CEO) |
Parexel (Group) |
United States (USA) |
Gelbke, Franz (Norgenta 200602) |
n. a. |
Hamburg (govt region) |
Germany |
Geller, Matthew (Geller Biopharm 2008– Managing Director + Founder before Rodman + Renshaw) |
Managing Director |
Geller Biopharm Inc. |
United States (USA) |
Geller, Patricia (Qiagen 2009 Director Corporate Strategy) |
Corporate Strategy Manager |
Qiagen (Group) |
Germany |
Gelone, Steven (Nabriva 20707– promoted COO joined 201412 before Spark Therapeutics + ViroPharma) |
Chief Operating Officer (COO) |
Nabriva (Group) |
Austria |
Gent, Ricardo (DIB 200503 Managing Director) |
Managing Director |
VCI (Verband der Chemischen Industrie e. V.) |
Germany |
Genth, Peter |
n. a. |
FIZ Technik (Group) |
Germany |